Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

831118

registered interest
date	26/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Liothyronine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many reports have been made by prescribers or patients to the Medicines and Healthcare products Regulatory Agency on unlicensed liothyronine.
tabling member constituency	Twickenham
tabling member printed	Sir Vince Cable
uin	125126
answer	answer is ministerial correction date of answer 31/01/2018 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) have received 124 spontaneous reports of suspected adverse drug reactions (ADRs) via the Yellow Card Scheme from prescribers and patients in association with liothyronine in the United Kingdom as of 28 January 2018. The MHRA have not received any spontaneous cases where the reporter has stated their liothyronine is unlicensed.</p><p> </p><p>Of the 124 reports, six relate to a brand of liothyronine that is not licensed in the UK. However, it is important to note that patients may have been prescribed a medication while in a foreign country; therefore, a report of a foreign brand cannot be assumed as unlicensed use. Furthermore, while reporters are requested to provide as much detail as possible, detail of the medicinal brand or license is not a compulsory reporting criteria. Therefore, this information is not always provided.</p><p> </p><p>Yellow Card data should not be used as an indicator of the frequency of suspected ADRs to medicines. The level of ADR reporting may fluctuate over time due to a variety of reasons such as a medicine being new, stimulated interest/publicity and variations in exposure to the medicine.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 31/01/2018 14:09:34 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	207 label Biography information for Sir Vince Cable

776100

registered interest
date	23/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the average waiting time was in each month since April 2015 for patients referred for primary care having suffered psychosis.
tabling member constituency	Twickenham
tabling member printed	Sir Vince Cable
uin	108997
answer	answer is ministerial correction date of answer 26/10/2017 answer text <p>Average waiting times for patients experiencing psychosis referred for primary care are not centrally held. NHS England publishes interim data on the percentage of patients with first episode of psychosis starting treatment within two weeks of referral, in line with the Early Intervention in Psychosis standard. This data has been available since December 2015 and it can be found at:</p><p> </p><p><a href="https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2016/04/EIP-Waiting-Times-Timeseries-August-2017.xlsx" target="_blank">https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2016/04/EIP-Waiting-Times-Timeseries-August-2017.xlsx</a></p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 26/10/2017 13:44:47 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	207 label Biography information for Sir Vince Cable

773342

registered interest
date	18/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Organs: Donors
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the potential effect on UK supplies of donated tissues and cells of the UK leaving the EU without formal agreement on the UK remaining party to Directive 2004/23/EC.
tabling member constituency	Twickenham
tabling member printed	Sir Vince Cable
uin	108475
answer	answer is ministerial correction date of answer 23/10/2017 answer text <p>The Department is working to ensure the best outcome for the health and social care system. All relevant policy areas covered by the Department are involved with this work and assessing the implications of the United Kingdom leaving the European Union.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 23/10/2017 16:43:05 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	207 label Biography information for Sir Vince Cable

773343

registered interest
date	18/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood: Donors
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the potential effect on blood supplies in the UK of the UK leaving the EU without formal agreement on the UK remaining party to Directive 2002/98/EC.
tabling member constituency	Twickenham
tabling member printed	Sir Vince Cable
uin	108476
answer	answer is ministerial correction date of answer 23/10/2017 answer text <p>The Department is working to ensure the best outcome for the health and social care system. All relevant policy areas covered by the Department are involved with this work and assessing the implications of the United Kingdom leaving the European Union.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 23/10/2017 16:44:29 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	207 label Biography information for Sir Vince Cable

759343

registered interest
date	11/09/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Attention Deficit Hyperactivity Disorder
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps the Government is taking to improve the (a) diagnosis, (b) early intervention and (c) treatment of attention deficit hyperactivity disorder and attention deficit disorder (i) in general and (ii) specifically for girls.
tabling member constituency	Twickenham
tabling member printed	Sir Vince Cable
uin	9775
answer	answer is ministerial correction date of answer 19/09/2017 answer text <p>The Department has asked the National Institute for Health and Care Excellence (NICE) to update its clinical guideline on attention deficit hyperactivity disorder (ADHD). The draft guideline, which was published for consultation on 6 September, provides evidence based recommendations on the diagnosis and management of ADHD in children, young people and adults.</p><p> </p><p>The draft guideline recognises that this condition is less likely to be diagnosed in girls and women or that they may be given an incorrect diagnosis as they are more likely to present with symptoms other than hyperactivity. The guideline advises practitioners to be alert in such circumstances to the possibility of ADHD.</p><p> </p><p>We expect clinical commissioning groups to take account of clinical guidelines published by NICE when commissioning services for their local populations. Whilst clinical guidelines are not mandatory, adherence to them will support improvements in the quality of care and services.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 19/09/2017 09:53:22 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	207 label Biography information for Sir Vince Cable